Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: BioArctic Says Leqembi Approved For The Treatment Of Alzheimer's Disease In UAE

Aug 13 (Reuters) - BioArctic AB  BIOAb.ST :
    * LEQEMBI APPROVED FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IN THE
UNITED ARAB EMIRATES
    * BIOARCTIC AB - IN CLARITY AD STUDY, LEQEMBI MET ITS
PRIMARY
ENDPOINT AND ALL KEY SECONDARY ENDPOINTS WITH STATISTICALLY
SIGNIFICANT RESULTS

Source text for Eikon:  ID:nWkr4m0SZS 
Further company coverage:  BIOAb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BioArctic AB

See all news